Treatment and chemoprevention of NSAID-associated gastrointestinal complications
- PMID: 19436617
- PMCID: PMC2697523
Treatment and chemoprevention of NSAID-associated gastrointestinal complications
Abstract
The use of non-steroidal anti-inflammatory drugs has become ubiquitous worldwide and remains a common source of gastrointestinal morbidity. Antisecretory medications, particularly proton pump inhibitors, are effective in the treatment and prevention of NSAID-related gastrointestinal complications, including peptic ulcer disease and non-ulcer dyspepsia. A careful assessment of patients' risk factors for developing NSAID-related gastrointestinal complications should be undertaken prior to initiation of any NSAIDs. Patients who are considered at risk for developing gastrointestinal complications should receive concurrent antisecretory medical therapy to minimize the risk for GI complications.
Figures
Similar articles
-
[Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):81-85. doi: 10.3760/cma.j.issn.0578-1426.2017.01.021. Zhonghua Nei Ke Za Zhi. 2017. PMID: 28056333 Chinese.
-
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. doi: 10.3310/hta11510. Health Technol Assess. 2007. PMID: 18021578 Review.
-
Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):755-73. doi: 10.1053/bega.2001.0233. Best Pract Res Clin Gastroenterol. 2001. PMID: 11566039 Review.
-
Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.Arthritis Res Ther. 2007;9(3):R52. doi: 10.1186/ar2207. Arthritis Res Ther. 2007. PMID: 17521422 Free PMC article.
-
Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications.Am J Med. 2004 Sep 6;117 Suppl 5A:63S-71S. doi: 10.1016/j.amjmed.2004.07.010. Am J Med. 2004. PMID: 15478855 Review.
Cited by
-
Peptic ulcer disease among dyspeptic patients at endoscopy unit, University of Gondar hospital, Northwest Ethiopia.BMC Gastroenterol. 2022 Apr 5;22(1):164. doi: 10.1186/s12876-022-02245-6. BMC Gastroenterol. 2022. PMID: 35382748 Free PMC article.
-
The clinical implications of heterotopic ossification in patients treated with radial head replacement for trauma: A case series and review of the literature.J Orthop. 2016 Jun 28;13(4):272-7. doi: 10.1016/j.jor.2016.06.011. eCollection 2016 Dec. J Orthop. 2016. PMID: 27408502 Free PMC article.
-
In Vivo Evidence for the Preventive Role of Vaccinium macrocarpon Aiton in Indomethacin-Induced Gastric Ulcer: Focusing on Antioxidant, Anti-Inflammatory and Anti-Apoptotic Mechanisms.Vet Med Sci. 2025 Jan;11(1):e70048. doi: 10.1002/vms3.70048. Vet Med Sci. 2025. PMID: 39745481 Free PMC article.
-
Treatments for Inflammatory Arthritis: Potential But Unproven Role of Topical Copaiba.Integr Med (Encinitas). 2017 Apr;16(2):40-42. Integr Med (Encinitas). 2017. PMID: 30881236 Free PMC article. Review.
-
Akt3 Regulates the Tissue-Specific Response to Copaiba Essential Oil.Int J Mol Sci. 2020 Apr 19;21(8):2851. doi: 10.3390/ijms21082851. Int J Mol Sci. 2020. PMID: 32325885 Free PMC article.
References
-
- Plymouth (PA): IMS Health; 2000. Retail and Provider Perspective, National Prescription Audit, 1999–2000.
-
- Sun SX, et al. Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization. Curr Med Res Opin. 2007;23:1859–1866. - PubMed
-
- Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348:883–890. - PubMed
-
- Zhang Y, Coogan PF, Palmer JR, et al. Use of nonsteroidal anti-inflammatory drugs and risk of breast cancer: the case-control surveillance study revisited. Am J Epidemiol. 2005;162:165–170. - PubMed
LinkOut - more resources
Full Text Sources